Captrust Financial Advisors »

Unicycive Therapeutics shares owned by Captrust Financial Advisors

Quarter-by-quarter ownership of Unicycive Therapeutics (UNCY) shares owned by Captrust Financial Advisors from 13F filings

Historical chart of Captrust Financial Advisors investment in Unicycive Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Unicycive Therapeutics held by Captrust Financial Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Unicycive Therapeutics by Captrust Financial Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $7.7k 19k 0.41
2024-06-30 $9.4k 19k 0.50
2024-03-31 $26k 19k 1.38
2023-12-31 $16k 19k 0.87
2023-09-30 $16k 19k 0.86
2023-06-30 $24k 19k 1.28
2023-03-31 $40k 19k 2.10
2022-09-30 $11k 19k 0.59

More positions owned by Captrust Financial Advisors

Ishares Core S&p 500 Etf Etf (IVV)
Apple Stock (AAPL)
Vanguard Value Etf (VTV)
Microsoft Corp Stock (MSFT)
Vanguard Ftse Developed Markets Etf Etf (VEA)
Ishares 7-10 Year Treasury Bond Etf Etf (IEF)
Ishares 1-3 Year Treasury Bond Etf Etf (SHY)
Vanguard S&p 500 Etf Etf (VOO)
Nvidia Corporation Stock (NVDA)
Ishares Core U.s. Aggregate Bond Etf Etf (AGG)
Vanguard Mega Cap Growth Etf Etf (MGK)
Vanguard Growth Etf Etf (VUG)
Vanguard Small-cap Etf Etf (VB)
Spdr S&p 500 Etf Trust Etf (SPY)
Ishares Core Msci Emerging Market Etf Etf (IEMG)

View all positions for Captrust Financial Advisors

Top funds holding Unicycive Therapeutics

Octagon Capital Advisors
Dr. Jeffrey R. Jay, M.D.
Logos Global Management
Nantahala Capital Management
Alyeska Investment Group
Vanguard Group
LPL Financial
Geode Capital Management
Goldman Sachs Group
Bleakley Financial Group
BlackRock
BlackRock
State Street Corporation
Jane Street
Northern Trust

View all funds holding Unicycive Therapeutics